Regulatory guidelines practices

Once the determinative or confirmatory method has been developed to take full advantage of the chemical properties of the analyte molecule, a study is necessary to prove that the method is valid. Criteria for method validation are outlined in guidelines from the US FDA, US EPA, and EU. A summary of the differences in regulatory requirements for method validation is provided in Table 3. The parameters addressed by all of the regulatory guidelines include accuracy, precision, sensitivity, specificity, and practicability. 

Worlds apart are the practices, yet the official policies and regulatory guidelines in developing countries show much influence from those of the developed world. While waste import bans are common in the developing world, the topography of recycling and disposal costs seems to assure a flow of e-waste out of the developed world down to the points of lowest-cost disposal. 

In addition, tests for mutagenicity and carcinogenicity are not likely required for most biopharma-ceutical substances. The regulatory guidelines and industrial practices relating to biopharmaceuti-cal preclinical trials thus remain in an evolutionary mode, and each product is taken on a case-by-case basis. An overview of the main preclinical tests undertaken for a sample biopharmaceutical... 

Statistical thinking and practice is very much determined by the regulatory guidelines that are in place. Primarily it is ICH E9 Statistical Principles for Clinical Trials , published in 1998, which sets down the broad framework within which we operate. In 2001 we saw the publication of ICH ElO Choice of Control Group which contained advice on the appropriate choice of concurrent control group and in particular first introduced the concept of assay sensitivity (see Section 12.5) in active control, non-inferiority trials. 

Anonymous (2005), New Zealand code of good manufacturing practice for manufacture and distribution of therapeutic goods, available http //www.medsafe.govt.nz/Regulatory/ Guideline/code.htm. 

Nick H. Anderson et al. followed up on this information by doing a then current United Kingdom industry practices survey in 1991 (222). This survey proved that the diversity of practices in sample presentation, source selection and exposure times and the need for regulatory guidelines. 

What is a Validation Master Plan There is no official definition however, based on the interpretation of FDA regulatory guidelines on current Good Manufacturing Practice (cGMP), Good Laboratory Practice, and process validation, a suitable definition may be described as ... 

---